Top Insider Purchases in December Signal Market Confidence
December has brought big insider purchases in shares of GE Aerospace and others. That was not the only notable insider buying seen, though.
Accendra Health, Inc. (NYSE: ACH) is a pure-play patient direct (home-based care) company. It provides products, technology and services that support health outside the hospital for people with chronic, complex and acute conditions.
It operates through its Apria and Byram brands. The business supplies:
- Soft goods: diabetes supplies, wound care, ostomy, urology, incontinence and breast pumps.
- Durable medical equipment: sleep equipment and CPAP supplies, oxygen, ventilators, HME/DME and negative pressure wound therapy.
The company connects patients, providers and insurers. Revenue is generated primarily through reimbursement from about 2,500 commercial payor contracts and other payors, serving roughly 2.9 million active patients nationwide.
Following the sale of its former Products & Healthcare Services business, continuing operations consist of the former Patient Direct segment. Under new CEO Kenny Gardner-Smith, the company is pursuing a turnaround and value creation plan. It is doing so while managing significant leverage, the loss of a large commercial payor contract and NYSE listing-standard noncompliance. Updated
December has brought big insider purchases in shares of GE Aerospace and others. That was not the only notable insider buying seen, though.
Friday's top analyst upgrades and downgrades included Altice USA, Apple, Colgate-Palmolive, Marathon Petroleum, Mastercard, Medtronic, Meta Platforms, Nike, Prologis, Realty Income, SLM, Tenaris and Visa.
Thursday's top analyst upgrades and downgrades included Boston Scientific, Caesars Entertainment, DraftKings, Fiserv, IBM, Medtronic, Norwegian Cruise Line, Pioneer Natural Resources and Raytheon Technologies.
24/7 Wall St. tracked six new secondary offerings that were announced after the close on Tuesday, September 29, 2020.
Accendra Health, Inc. (NYSE: ACH) is a pure-play patient direct (home-based care) company. It provides products, technology and services that support health outside the hospital for people with chronic, complex and acute conditions.